Stewart Bitman
Gastroenterology · Coral Springs, FLNPI 1356389019
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 25.0% of the total. Reporting peaked in 2019 at $2,300 and has fallen 95.4% since, to $105 in 2023.
Across 261 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$950
- Johnson & Johnson$509
- Takeda Pharmaceuticals U.S.A., Inc.$378
- Redhill Biopharma Inc.$198
- Shire North American Group Inc$177
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,48998%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 67 | $1,147 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 55 | $950 |
| Johnson & Johnson | 31 | $509 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $378 |
| Redhill Biopharma Inc. | 11 | $198 |
| Shire North American Group Inc | 19 | $177 |
| Gilead | 10 | $169 |
| Daiichi Sankyo Inc. | 2 | $150 |
| Intercept Pharmaceuticals, Inc. | 7 | $121 |
| Pfizer | 6 | $112 |
| Boston Scientific | 2 | $105 |
| Braintree Laboratories, Inc. | 6 | $90 |
| UCB, Inc. | 5 | $73 |
| Ironwood Pharmaceuticals, Inc | 4 | $73 |
| Evoke Pharma, Inc. | 4 | $51 |
| Merck | 3 | $51 |
| Concordia Pharmaceuticals Inc. | 2 | $46 |
| Cook Medical LLC | 2 | $41 |
| Cumberland Pharmaceuticals, Inc. | 2 | $27 |
| Alfasigma USA, Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Ambu Inc. | 1 | $20 |
| Shionogi Inc | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$125
- XIFAXAN$118
How this compares
$4,588 in reported general payments places this provider in the 60th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Coral Springs
- Ronen AraiCoral Springs$1.1M
- Jeffrey SchneiderCoral Springs$344K
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.